485 related articles for article (PubMed ID: 18406571)
1. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
Ase AR; Reader TA; Hen R; Descarries L
J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
3. Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice.
Short JL; Ledent C; Borrelli E; Drago J; Lawrence AJ
Neuroscience; 2006 May; 139(2):661-70. PubMed ID: 16476524
[TBL] [Abstract][Full Text] [Related]
4. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
Talbot JN; Happe HK; Murrin LC
J Pharmacol Exp Ther; 2005 Aug; 314(2):596-602. PubMed ID: 15860573
[TBL] [Abstract][Full Text] [Related]
5. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
Adlersberg M; Hsiung SC; Glickstein SB; Liu KP; Tamir H; Schmauss C
J Neurochem; 2004 Aug; 90(4):865-73. PubMed ID: 15287892
[TBL] [Abstract][Full Text] [Related]
6. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
[TBL] [Abstract][Full Text] [Related]
7. Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice.
Montague DM; Striplin CD; Overcash JS; Drago J; Lawler CP; Mailman RB
Synapse; 2001 Mar; 39(4):319-22. PubMed ID: 11169782
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV.
Tchekalarova J; Sotiriou E; Angelatou F
Brain Res; 2004 Oct; 1024(1-2):159-66. PubMed ID: 15451378
[TBL] [Abstract][Full Text] [Related]
9. The effect of chronic ethanol consumption and withdrawal on mu-opioid and dopamine D(1) and D(2) receptor density in Fawn-Hooded rat brain.
Djouma E; Lawrence AJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):551-9. PubMed ID: 12130715
[TBL] [Abstract][Full Text] [Related]
10. Differential propensity to ethanol sensitization is not associated with altered binding to D1 receptors or dopamine transporters in mouse brain.
Quadros IM; Nobrega JN; Hipólide DC; de Lucca EM; Souza-Formigoni ML
Addict Biol; 2002 Jul; 7(3):291-9. PubMed ID: 12126488
[TBL] [Abstract][Full Text] [Related]
11. Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgrounds.
Yoo JH; Bailey A; Ansonoff M; Pintar JE; Matifas A; Kieffer BL; Kitchen I
Synapse; 2010 Jul; 64(7):520-7. PubMed ID: 20196137
[TBL] [Abstract][Full Text] [Related]
12. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts.
Stanwood GD; Parlaman JP; Levitt P
Eur J Neurosci; 2006 Aug; 24(3):806-18. PubMed ID: 16930410
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice.
Delis F; Mitsacos A; Giompres P
Neuroscience; 2004; 125(1):255-68. PubMed ID: 15051164
[TBL] [Abstract][Full Text] [Related]
14. Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.
Efange SM; Mash DC; Khare AB; Ouyang Q
J Med Chem; 1998 Nov; 41(23):4486-91. PubMed ID: 9804688
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain.
O'Connor KA; Gregg TC; Davies HM; Childers SR
Neuropharmacology; 2005 Jan; 48(1):62-71. PubMed ID: 15617728
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of the dopamine D4 receptor in the mouse brain.
Defagot MC; Falzone TL; Low MJ; Grandy DK; Rubinstein M; Antonelli MC
J Neurosci Res; 2000 Jan; 59(2):202-8. PubMed ID: 10650878
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
Ryoo HL; Pierrotti D; Joyce JN
Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
[TBL] [Abstract][Full Text] [Related]
18. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
[TBL] [Abstract][Full Text] [Related]
19. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
Hall FS; Sora I; Hen R; Uhl GR
PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
[TBL] [Abstract][Full Text] [Related]
20. Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration.
Bailey A; Yoo JH; Racz I; Zimmer A; Kitchen I
J Neurochem; 2007 Sep; 102(6):1817-1830. PubMed ID: 17532787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
